BC
BIIB icon

Broadwater Capital’s Biogen BIIB Stock Holding History

Broadwater Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6K Hold
100
– – 0.02% 132
2026
Q1 		$17.6K Hold
100
– – 0.01% 136
2025
Q4 		$17.6K Hold
100
– – 0.01% 136
2025
Q3 		$14K Sell
100
-12,459
-99% -$1.68M 0.01% 148
2025
Q2 		$12.6M Buy
12,559
+12,459
+12,459% +$1.55M 0.01% 152
2025
Q1 		$13.7K Hold
100
– – 0.01% 146
2024
Q4 		$15.3K Sell
100
-40
-29% -$6.75K 0.01% 148
2024
Q3 		$27.1K Hold
140
– – 0.02% 133
2024
Q2 		$32.5K Hold
140
– – 0.03% 128
2024
Q1 		$30.2K Hold
140
– – 0.02% 132
2023
Q4 		$36.2K Buy
+140
New +$34.4K 0.03% 127

Other funds holding BIIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Broadwater Capital's BIIB Position: Q2 2026 in Review

Broadwater Capital held its Biogen (BIIB) position steady in Q2 2026 at 100 shares worth $21.6K. The position accounts for 0.02% of the portfolio, ranked #132.

Broadwater Capital first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. The position peaked at $12.6M in Q2 2025. 498 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Broadwater Capital held 100 shares of Biogen worth $21.6K as of Q2 2026.
  • Broadwater Capital left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.02% of Broadwater Capital's portfolio in Q2 2026, its #132 holding.
  • Broadwater Capital first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
  • Broadwater Capital's Biogen position peaked at $12.6M in Q2 2025.
  • 498 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.